Key stakeholders
These are the current top-level decision-makers at the company and their LinkedIn profiles. Check them for recent activity and updates
Latest news about McKesson
Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates
McKesson reported fiscal 2025 second-quarter results with record revenue of $93.7 billion, a 21% increase, and a 13% rise in adjusted earnings per diluted share to $7.07. The company announced the acquisition of a controlling interest in Florida Cancer Specialists & Research Institute and the sale of its Canada-based Rexall and Well.ca retail businesses[1].
McKesson launched InspiroGene, a dedicated business to support the commercialization of cell and gene therapies, offering services such as third-party logistics, specialty distribution, biologics specialty pharmacy solutions, and a patient hub to navigate the complex CGT commercialization landscape[3].
McKesson announced the sale of its Canada-based Rexall and Well.ca retail businesses to Birch Hill Equity Partners, aligning with its strategy to focus on oncology and biopharma services, while continuing to supply these businesses as a wholesale distributor until the transaction closes[2].
Open job positions at McKesson
This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.